Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 14, 2026 | $0.19 | +533.3% | $321.38M | +9.2% | $0.25 |
| Q1 FY26ended Mar 31, 2026 | May 7, 2026 | $0.09 | — | $280.05M | +10.0% | $0.17 |
| Q4 FY25ended Dec 31, 2025 | — | $0.12 | +200.0% | $303.44M | +4.6% | — |
| Q3 FY25ended Sep 30, 2025 | — | $0.17 | +183.3% | $311.31M | +9.1% | — |
| Q2 FY25ended Jun 30, 2025 | — | $0.03 | +0.0% | $294.34M | +6.4% | — |
| Q1 FY25ended Mar 31, 2025 | — | −$0.05 | −350.0% | $254.52M | +2.6% | — |
| Q4 FY24ended Dec 31, 2024 | — | $0.04 | −71.4% | $290.20M | −6.5% | — |
| Q3 FY24ended Sep 30, 2024 | — | $0.06 | — | $285.47M | +8.5% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Sotera Health shares, not any token. As of Aug 14, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $0.03 | — | $276.59M | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.02 | — | $248.18M | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $0.14 | — | $310.24M | — | — |
| Q3 FY23ended Sep 30, 2023 | — | −$0.05 | — | $263.18M | — | — |